MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, July 20, 2017 -- ReWalk Robotics Ltd. (Nasdaq:RWLK), a leading manufacturer of exoskeleton systems, will release its second quarter 2017 financial results on Thursday, August 3, 2017, before the U.S. financial markets open.
Larry Jasinski, Chief Executive Officer, and Kevin Hershberger, Chief Financial Officer, will host a conference call to discuss the results as follows:
| Time | 8:30 a.m. EDT | |||
| Toll free (U.S.) | (844) 423-9889 | |||
| International | (716) 247-5804 | |||
| Israel | 18 09 45 78 77 | |||
| Webcast (live and replay) | www.rewalk.com under the ‘Investors’ section. |
A replay of the conference call will be available for two weeks after the call's completion by dialing (855) 859-2056 (U.S.) or (404) 537-3406 (International). The conference ID for the replay is 47740857. The archived webcast will be available for 30 days via the aforementioned URL.
About ReWalk Robotics Ltd.
ReWalk Robotics Ltd. develops, manufactures and markets wearable robotic exoskeletons for individuals with spinal cord injury. ReWalk’s mission is to fundamentally change the quality of life for individuals with lower limb disability through the creation and development of market leading robotic technologies. Founded in 2001, ReWalk has headquarters in the U.S., Israel and Germany. For more information on the ReWalk systems, please visit www.rewalk.com.
ReWalk® is a registered trademark of ReWalk Robotics Ltd. in Israel.
Contact: Lisa Wilson In-Site Communications, Inc. Investor Relations T: (212) 452-2793 E: [email protected]


Cathay Pacific Holds Firm on Flight Capacity Amid Middle East Conflict and Rising Fuel Costs
Apple Turns 50: From Garage Startup to AI Crossroads
MATCH Act Targets ASML and Chinese Chipmakers in New U.S. Export Crackdown
UAE's Largest Natural Gas Facility Suspended After Attack-Triggered Fire
Luxury Car Sales in the Middle East Take a Hit Amid Iran War
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
Ukrainian Drones and the #MadeByHousewives Movement: Kyiv Fires Back at Rheinmetall CEO
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
UPS and Teamsters Reach Agreement to Limit Driver Severance Program
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition
Private Credit Under Pressure: Is a Slow-Motion Crisis Unfolding?
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
Jefferies Upgrades Sodexo to Buy With €55 Target After Historic CEO Appointment
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
Samsung Electronics Eyes Record Q1 Profit Amid AI-Driven Chip Boom 



